Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Murthy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Talanta|October 1, 1989
Oxidation of thiols by sodium N-haloarylsulphonamidesA S Murthy, S A Murthy, D S Mahadevappa
Indian Journal of Cancer|May 23, 2002
Cure in a case of primary hepatic lymphomaS A Murthy, B Singh, S Bhalla, et al.
Stem Cells (Dayton, Ohio)|January 1, 1993
Interleukin-2: use in solid tumorsR M Bukowski, D McLain, T Olencki, et al.
The Journal of the Association of Physicians of India|October 5, 2001
Biatrial tuberculosisS A Murthy, R Dhall, S Jain, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effectsR M Bukowski, S A Murthy, J Finke, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Talanta|October 1, 1989
Oxidation of thiols by sodium N-haloarylsulphonamidesA S Murthy, S A Murthy, D S Mahadevappa
Indian Journal of Cancer|May 23, 2002
Cure in a case of primary hepatic lymphomaS A Murthy, B Singh, S Bhalla, et al.
Stem Cells (Dayton, Ohio)|January 1, 1993
Interleukin-2: use in solid tumorsR M Bukowski, D McLain, T Olencki, et al.
The Journal of the Association of Physicians of India|October 5, 2001
Biatrial tuberculosisS A Murthy, R Dhall, S Jain, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effectsR M Bukowski, S A Murthy, J Finke, et al.
Pageof 1